These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1010 related articles for article (PubMed ID: 2157887)
1. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23. Wang F; Gregory C; Sample C; Rowe M; Liebowitz D; Murray R; Rickinson A; Kieff E J Virol; 1990 May; 64(5):2309-18. PubMed ID: 2157887 [TBL] [Abstract][Full Text] [Related]
2. Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23. Cordier M; Calender A; Billaud M; Zimber U; Rousselet G; Pavlish O; Banchereau J; Tursz T; Bornkamm G; Lenoir GM J Virol; 1990 Mar; 64(3):1002-13. PubMed ID: 2154588 [TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23. Wang F; Gregory CD; Rowe M; Rickinson AB; Wang D; Birkenbach M; Kikutani H; Kishimoto T; Kieff E Proc Natl Acad Sci U S A; 1987 May; 84(10):3452-6. PubMed ID: 3033649 [TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation. Cohen JI; Wang F; Kieff E J Virol; 1991 May; 65(5):2545-54. PubMed ID: 1850028 [TBL] [Abstract][Full Text] [Related]
6. Up regulation of the Epstein-Barr virus (EBV)-encoded membrane protein LMP in the Burkitt's lymphoma line Daudi after exposure to n-butyrate and after EBV superinfection. Contreras-Salazar B; Ehlin-Henriksson B; Klein G; Masucci MG J Virol; 1990 Nov; 64(11):5441-7. PubMed ID: 2170681 [TBL] [Abstract][Full Text] [Related]
7. Expression of the Epstein-Barr virus (EBV)-encoded membrane antigen (LMP) increases the stimulatory capacity of EBV-negative B lymphoma lines in allogeneic mixed lymphocyte cultures. Cuomo L; Trivedi P; Wang F; Winberg G; Klein G; Masucci MG Eur J Immunol; 1990 Oct; 20(10):2293-9. PubMed ID: 2173662 [TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus nuclear protein 2 transactivates a cis-acting CD23 DNA element. Wang F; Kikutani H; Tsang SF; Kishimoto T; Kieff E J Virol; 1991 Aug; 65(8):4101-6. PubMed ID: 1649318 [TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells. Allday MJ; Crawford DH; Thomas JA J Gen Virol; 1993 Mar; 74 ( Pt 3)():361-9. PubMed ID: 8383171 [TBL] [Abstract][Full Text] [Related]
10. Transient expression of the Epstein-Barr virus LMP1 gene in B-cell chronic lymphocytic leukemia cells, T cells, and hematopoietic cell lines: cell-type-independent-induction of CD23, CD21, and ICAM-1. Peng M; Lundgren E Leukemia; 1993 Jan; 7(1):104-12. PubMed ID: 8093369 [TBL] [Abstract][Full Text] [Related]
11. Induced CD25 expression in a human B-lymphoma cell line transfected with the Epstein-Barr virus nuclear antigen 2 gene. Harada S; Yanagi K Microbiol Immunol; 1992; 36(5):479-94. PubMed ID: 1325025 [TBL] [Abstract][Full Text] [Related]
12. B cell phenotype-dependent expression of the Epstein-Barr virus nuclear antigens EBNA-2 to EBNA-6: studies with somatic cell hybrids. Contreras-Brodin BA; Anvret M; Imreh S; Altiok E; Klein G; Masucci MG J Gen Virol; 1991 Dec; 72 ( Pt 12)():3025-33. PubMed ID: 1662694 [TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus-specific cytotoxic T-cell recognition of transfectants expressing the virus-coded latent membrane protein LMP. Murray RJ; Wang D; Young LS; Wang F; Rowe M; Kieff E; Rickinson AB J Virol; 1988 Oct; 62(10):3747-55. PubMed ID: 2843672 [TBL] [Abstract][Full Text] [Related]
14. Transient expression of the Epstein-Barr virus LMP1 gene in human primary B cells induces cellular activation and DNA synthesis. Peng M; Lundgren E Oncogene; 1992 Sep; 7(9):1775-82. PubMed ID: 1354347 [TBL] [Abstract][Full Text] [Related]
15. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line. Gregory CD; Rowe M; Rickinson AB J Gen Virol; 1990 Jul; 71 ( Pt 7)():1481-95. PubMed ID: 2165133 [TBL] [Abstract][Full Text] [Related]
16. Selective induction of allostimulatory capacity after 5-azaC treatment of EBV carrying but not EBV negative Burkitt lymphoma cell lines. Cuomo L; Trivedi P; de Campos-Lima PO; Zhang QJ; Ragnar E; Klein G; Masucci MG Mol Immunol; 1993 Apr; 30(5):441-50. PubMed ID: 7681932 [TBL] [Abstract][Full Text] [Related]
17. Analysis of viral gene expression and genome persistence in CD23-positive and -negative subpopulations of Epstein-Barr-virus-infected BL2 cells. Doyle MG; Crawford DH Intervirology; 1994; 37(5):236-44. PubMed ID: 7698878 [TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein. Abbot SD; Rowe M; Cadwallader K; Ricksten A; Gordon J; Wang F; Rymo L; Rickinson AB J Virol; 1990 May; 64(5):2126-34. PubMed ID: 2157875 [TBL] [Abstract][Full Text] [Related]
19. The Epstein-Barr virus latent membrane protein-1 (LMP1) induces interleukin-10 production in Burkitt lymphoma lines. Nakagomi H; Dolcetti R; Bejarano MT; Pisa P; Kiessling R; Masucci MG Int J Cancer; 1994 Apr; 57(2):240-4. PubMed ID: 8157362 [TBL] [Abstract][Full Text] [Related]
20. Transcriptional regulation of the human IgE receptor (Fc epsilon RII/CD23) by EBV. Identification of EBV-responsive regulatory elements in intron 1. Lacy J; Rudnick H J Immunol; 1992 Mar; 148(5):1554-60. PubMed ID: 1311350 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]